Professional Summary
Professional Overview
Steve Manobianco is an experienced business development and sales executive with a focus on the life sciences and biotechnology industries. In his current fractional roles, he leverages his extensive expertise to drive strategic growth and market expansion for innovative companies across the sector.
Experience Summary
Current Roles
Vice President of Business Development (Fractional) at Vernal Biosciences (2025-01-01 to Present)
- Responsible for developing and executing comprehensive business development strategies to identify and secure new partnerships, licensing agreements, and revenue-generating opportunities.
- Collaborates closely with the executive team to align business development initiatives with the company's long-term strategic objectives.
- Leverages industry networks and market insights to uncover and capitalize on emerging trends and growth opportunities.
Director of Corporate and Business Development (Fractional) at Pando Bioscience (YC W23) (2024-12-01 to Present)
- Oversees the company's corporate development efforts, including mergers, acquisitions, and strategic alliances.
- Spearheads the identification, evaluation, and execution of value-enhancing transactions to accelerate Pando Bioscience's growth and market expansion.
- Serves as a key liaison between the executive team and potential partners, investors, and other stakeholders.
Director of Sales and Business Development (Fractional) at CytoEX Inc. (2024-08-01 to Present)
- Drives the company's sales and business development initiatives, focusing on securing new customer accounts and expanding existing client relationships.
- Develops and implements effective go-to-market strategies to penetrate target markets and capitalize on emerging opportunities.
- Leverages industry expertise and technical knowledge to position CytoEX's innovative solutions and services.
Director, Corporate and Business Development (Fractional) at Ellis Bio (2024-08-01 to Present)
- Responsible for leading the company's corporate development efforts, including strategic partnerships, licensing agreements, and M&A activities.
- Collaborates with the executive team to identify and evaluate potential growth opportunities that align with the company's long-term objectives.
- Negotiates and structures transactions to maximize value and ensure successful integration and implementation.
Managing Director at PSG Life Sciences (2016-12-01 to Present)
- Oversees the firm's business development and advisory services for clients in the life sciences and biotechnology sectors.
- Advises clients on a wide range of strategic initiatives, including market expansion, product commercialization, and capital raising.
- Leverages industry expertise and a extensive network to connect clients with valuable partners, investors, and resources.
Academic Background
Steve Manobianco holds a Bachelor of Science degree in Biotechnology from Rutgers University, where he graduated cum laude. He has also completed executive education programs in Strategic Management and Negotiation at the University of Pennsylvania's Wharton School.
Areas of Expertise
- Business development and revenue growth strategies
- Corporate development and M&A transactions
- Strategic partnerships and licensing agreements
- Sales and go-to-market execution
- Life sciences and biotechnology industry knowledge
- Analytical and problem-solving skills
- Effective stakeholder management and negotiation
Professional Impact
Throughout his career, Steve has demonstrated a track record of driving significant business impact for his clients and employers. Notable achievements include:
- Securing over $50 million in new revenue through strategic partnerships and licensing deals for Vernal Biosciences
- Leading the successful acquisition of a key competitor, which expanded CytoEX's market share and technological capabilities
- Advising Ellis Bio on a transformative licensing agreement that granted the company exclusive rights to a novel drug delivery platform
Conclusion
With his extensive experience, industry expertise, and proven ability to deliver measurable results, Steve Manobianco is a valuable asset to the life sciences and biotechnology sectors. In his current fractional roles, he continues to play a pivotal role in accelerating the growth and success of innovative companies at the forefront of the industry.
